Health & Biotech ASX Health Stocks: Pharmaxis gets $5m to fund groundbreaking collaboration study of lead drug PXS‐4728 September 1, 2022 Leading charity, Parkinson’s UK will provide £2.9m (~$5m) to fund a Phase 2 study of the Pharmaxis (ASX:PXS) drug, PXS‐4728. Opyl prepares to launch Opin into the global $4.7 billion clinical trial recruitment market September 1, 2022 Special Report: Opyl’s flagship platform Opin is ready to be launched internationally, while Trial Key is set to be a… Nutritional Growth Solutions reaches healthy heights in H1 FY22, future growth looks strong August 31, 2022 Special Report: Nutritional Growth Solutions has completed a milestone H1 FY22 which has set it up for future strong growth… EZZ’s remained ‘disciplined’ to deliver successful end to FY22 August 31, 2022 Special Report: EZZ is a rare biotech on the ASX turning a profit with its FY22 results showing it remains… NeuroScientific achieves key milestones in FY22, advancing lead drug EmtinB for treatment of MS August 31, 2022 Special Report: NeuroScientific Biopharmaceuticals has described FY22 as a landmark year, after it achieved an historic milestone by starting the… ASX Health Stocks: Immutep now patently Japanese; Patrys preps Phase 1 trial of brain cancer drug August 30, 2022 Immutep gets patent in Japan Patrys completes engineering run, prepares for Phase 1 trial Bod set to acquire Aqua Phase… HealthKick Podcast: NGS’s growth just accelerated with launch into 403 select Walmart stores August 30, 2022 Tim chats with Liron Fendell, CEO and managing director of Nutritional Growth Solutions (ASX:NGS) on their US expansion plans. ASX Health Stocks: HITIQ signs renewed deal with English cricket to manage concussion injuries August 29, 2022 HITIQ (ASX:HIQ) has renewed a subscription agreement with the English Cricket Broad (ECB) for another two years. ASX Health Stocks: Patrys wins fresh grant, IDT does not and Next Science is off to sell stuff in Canada August 26, 2022 Patrys gets research grant to progress lead drug Next Science gets Canada license Bad news for IDT Australia Cancer fighter… Weed Week: Legal use of medicinal cannabis in Australia on the rise, Lambert Initiative says August 26, 2022 Researchers say data shows transition from illicit to legal use of cannabis, with medicinal users up 34.5% since 2018. Next» « Previous